William concentrates his intellectual property practice on patent litigation and strategic counseling. He has extensive experience before federal district courts, in appellate proceedings, and in inter partes review proceedings at the US Patent and Trademark Office. He represents companies in the life sciences and technology industries, with a particular focus on biotech and biologic drug developers.

As a versatile practitioner with a biomedical engineering background, William brings a deep understanding of small molecule and biologic drugs, medical devices, and emerging technologies such as CRISPR and immunotherapy. He also has deep knowledge of navigating the complexities of Hatch-Waxman and Biologics Price Competition and Innovation Act (BPCIA) litigation frameworks. Clients also rely on him to conduct infringement and validity analyses, and advise on patent and regulatory issues related to drug development.

In addition, William maintains an active pro bono practice that has included working on immigration matters. He has also been named one of Best Lawyers in America’s “Ones to Watch” in  Intellectual Property Law and served on a team that twice received the Washington Lawyers’ Committee’s Outstanding Achievement Award.

Prior to joining Mintz, William practiced at two international law firms, where he represented life sciences clients in a broad spectrum of patent litigation matters. 

In law school, William earned the Thomas Jefferson Award for the best Note in the William & Mary Bill of Rights Journal, Vol. 22, received a CALI Excellence for the Future Award in Copyright Law, and was selected to the Phi Delta Phi Legal Honor Society.  Before law school, William studied biomedical engineering at the University of Virginia as a Rodman Scholar and contributed to research on targeted cancer treatments using ultrasound and nanotechnology.  He also worked as an emergency medical technician.